A funny thing happened on the way to the US Supreme Court this week - a few justices had to recuse themselves from a case because they held stock in companies with a matter before the court. Justice Samuel Alito, for instance, holds shares in Bristol-Myers Squibb.
This was the second recent instance in which a [...]

The US Supreme Court can’t intervene in an important dispute over the rights of apartheid victims to sue US corporations in US courts because four of the nine justices had to sit out the case over apparent conflicts, including stockholdings in Bristol-Myers Squibb, the Associated Press writes.
The result is that a lawsuit accusing some prominent [...]

This time, it’s in Europe. Switzerland’s Schweizerhall expects to market a lower-priced version of the widely used blood thinner within the month, and the news sent Sanofi-Aventis shares plummeting.
“The German authorities have basically finished the registration procedure and we’re now just waiting for the paperwork,” Luzi Andreas von Bidder, Schweizerhall’s chairman, tells Bloomberg News. The [...]

Nice to see you again. We hope your week has gone well. As usual, we have been quite busy and look forward to a respite this weekend. Still, there is much to be done. So please join us as we grab our daily cup of stimulation and catch up with events. Hope your day goes [...]

Two years ago, the drugmaker refused to sell the cancer med in Canada because the government board that regulates the cost of patented meds decided the price would have been too high. Now, though, Bristol-Myers has agreed to sell Erbiux and at a price lower than it had wanted, The Globe and Mail reports.
A Bristol-Myers spokesman says [...]

What’s the pharmaceutical angle here? Well, let’s see. Perhaps as the cost of oil continues to climb, oil companies will supplant drugmakers as the industry that upsets people most. You know, it’s called deflecting attention. And for all those overworked ceo’s - not to mention the thousands of employees who never promoted a drug off-label [...]

Andrew Bodnar, once a senior vice president, was charged by the US Department of Justice with lying to federal authorities about a botched patent deal involving the Plavix blood thinner. You may recall Bristol-Myers Squibb has already pleaded guilty and paid a $1 million fine for misleading the government about the deal, which included a [...]

Genentech’s blockbuster cancer drug Avastin faces a big challenge from ImClone Systems’ Erbitux in lung cancer, according to a Morgan Stanley investor note that cites unpublished data, Reuters reports. The brokerage has learned from what it calls “a reliable public source” that ImClone’s med had demonstrated an unexpected survival benefit in a second Phase III [...]

Four years ago, Lilly and several other drugmakers proposed the creation of The Florida Behavioral Health Collaborative. And they provided $10 million to the state to get it up and running. Soon, an expert panel was convened and recommended state standards, and national scholars with financial ties to drugmakers that sell atypicals were invited to [...]

File this under ‘Say Uncle.’ A dozen drug and device makers have told Chuck Grassley, the Iowa Republican, that they have plans or are working on plans to publicly disclose grants to outside groups, and the details will be provided on each company’s Web sites, the Associated Press reports. In particular, Grassley is interested in [...]